Recent

% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • jetmanbash jetmanbash Dec 21, 2010 8:23 AM Flag

    Competiton update:

    Johnson & Johnson: Centocor Ortho Biotech has submitted NDA to FDA for the investigational drug abiraterone acetate (62.49)
    Centocor Ortho Biotech has submitted NDA to FDA for the investigational drug abiraterone acetate administered with prednisone for the treatment of metastatic advanced prostate cancer in patients who have received prior chemotherapy containing a taxane. Janssen-Cilag International NV also filed a marketing authorization application (MAA) with the European Medicines Agency (EMA) for abiraterone acetate.

 
OGXI
2.24-0.06(-2.61%)Jun 2 3:59 PMEDT